The percentage of CA125-deficient ovarian cancers expressing DF3 (95%), vascular endothelial growth factor (VEGF) (81%), MUC1 (62%), mesothelin (MES) (34%), HE4 (32%), and CA19 is low-9 (29%). Here, VEGFA is linked to ovarian cancer.